Identification of surface proteins of group B streptococci: Serotyping versus genotyping

Journal of Microbiological Methods

Volumn 78, Issue 3, 2009, Pages 363-365

  Radtke, Andreas ^a,b   Kong, Fanrong ^c   Bergh, Kåre ^a,b   Lyng, Randi Valsø ^b   Ko, Danny ^c   Gilbert, Gwendolyn L ^c  

^a NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^b TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^c Western Sydney Area Health Service   (Australia)

Author keywords

GBS; Genotyping; Serotyping; Streptococcus agalactiae; Surface protein

Indexed keywords

MEMBRANE PROTEIN; MONOCLONAL ANTIBODY;

ARTICLE; AUSTRALIA AND NEW ZEALAND; BACTERIUM CULTURE; BACTERIUM IDENTIFICATION; BACTERIUM ISOLATE; CONTROLLED STUDY; GENOTYPE; HUMAN; HYBRIDIZATION; IMMUNOFLUORESCENCE; INTERMETHOD COMPARISON; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ANALYSIS; SEROTYPING; STREPTOCOCCUS AGALACTIAE;

AUSTRALIA; BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; GENOTYPE; MEMBRANE PROTEINS; MOLECULAR EPIDEMIOLOGY; SEROTYPING; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS AGALACTIAE;

STREPTOCOCCUS AGALACTIAE; STREPTOCOCCUS SP. 'GROUP B';

EID: 68949150755     PISSN: 01677012     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mimet.2009.06.017     Document Type: Article

References (28)

1. Bevanger L., and Maeland J.A. Type classification of group B streptococci by the fluorescent antibody test. Acta Pathol.Microbiol.Scand.[B]. 85B (1977) 357-362
2. Bevanger L., Iversen O.J., and Naess A.I. Characterization of the alpha antigen of the c proteins of group B streptococci (GBS) using a murine monoclonal antibody. APMIS 100 (1992) 57-62
3. Cole J.N.J.N. Human pathogenic streptococcal proteomics and vaccine development. Proteomics 2 (2008) 387-410
4. Gravekamp C., Horensky D.S., Michel J.L., and Madoff L.C. Variation in repeat number within the alpha C protein of group B streptococci alters antigenicity and protective epitopes. Infect. Immun. 64 (1996) 3576-3583
5. Johri A.K., Paoletti L.C., Glaser P., Dua M., Sharma P.K., Grandi G., and Rappuoli R. Group B Streptococcus: global incidence and vaccine development. Nat. Rev. Microbiol. 4 (2006) 932-942
6. Kong F., and Gilbert G.L. Multiplex PCR-based reverse line blot hybridization assay (mPCR/RLB) - a practical epidemiological and diagnostic tool. Nat. Protoc. 1 (2006) 2668-2680
7. Kong F., Gowan S., Martin D., James G., and Gilbert G.L. Molecular profiles of group B streptococcal surface protein antigen genes: relationship to molecular serotypes. J. Clin. Microbiol. 40 (2002) 620-626
8. Kong F., Ma L., and Gilbert G.L. Simultaneous detection and serotype identification of Streptococcus agalactiae using multiplex PCR and reverse line blot hybridization. J. Med. Microbiol. 54 (2005) 1133-1138
9. Kong F.F., Lambertsen L.M.L.M., Slotved H.C.H.-C., Ko D.D., Wang H.H., and Gilbert G.L.G.L. Use of phenotypic and molecular serotype identification methods to characterize previously nonserotypeable group B streptococci. J. Clin. Microbiol. 46 (2008) 2745-2750
10. Kvam A.I., Efstratiou A., Bevanger L., Cookson B.D., Marticorena I.F., George R.C., and Maeland J.A. Distribution of serovariants of group B streptococci in isolates from England and Norway. J. Med. Microbiol. 42 (1995) 246-250
11. Kvam A.I., Bevanger L., and Maeland J.A. Properties and distribution of the putative R3 protein of Streptococcus agalactiae. APMIS 107 (1999) 869-874
12. Lachenauer C.S., Creti R., Michel J.L., and Madoff L.C. Mosaicism in the alpha-like protein genes of group B streptococci. Proc. Natl. Acad. Sci. U.S.A. 97 (2000) 9630-9635
13. Maeland J.A., Bevanger L., and Lyng R.V. Antigenic determinants of alpha-like proteins of Streptococcus agalactiae. Clin. Diagn. Lab. Immunol. 11 (2004) 1035-1039
14. Maeland J.A., Bevanger L., and Lyng R.V. Immunological markers of the R4 protein of Streptococcus agalactiae. Clin. Diagn. Lab. Immunol. 12 (2005) 1305-1310
15. Mavenyengwa R.T., Maeland J.A., and Moyo S.R. Distinctive features of surface-anchored proteins of Streptococcus agalactiae strains from Zimbabwe revealed by PCR and dot blotting. Clin. Vaccine Immunol. 15 (2008) 1420-1424
16. Moyo S.R., Maeland J.A., and Lyng R.V. The putative R1 protein of Streptococcus agalactiae as serotype marker and target of protective antibodies. APMIS 109 (2001) 842-848
17. Moyo S.R., Maeland J.A., and Bergh K. Typing of human isolates of Streptococcus agalactiae (group B streptococcus, GBS) strains from Zimbabwe. J. Med. Microbiol. 51 (2002) 595-600
18. Naess A.I., Bevanger L., Iversen O.J., and Maeland J.A. Evaluation of monoclonal antibodies in serovar classification of group B streptococci (GBS). Brief report. APMIS 99 (1991) 1058-1060
19. Nizet V., and Rubens C.E. In: Fischetti V.A., Novick R.P., Ferretti J.J., Portnoy D.A., and Rood J.I. (Eds). Pathogenic mechanisms and virulence factors of group B streptococci Vol. 2nd (2006), ASM Press, Washington, DC 152-168
20. Pannaraj P.S., Kelly J.K., Rench M.A., Madoff L.C., Edwards M.S., and Baker C.J. Alpha C protein-specific immunity in humans with group B streptococcal colonization and invasive disease. Vaccine 26 (2008) 502-508
21. Persson E., Berg S., Bevanger L., Bergh K., Valso-Lyng R., and Trollfors B. Characterisation of invasive group B streptococci based on investigation of surface proteins and genes encoding surface proteins. Clin. Microbiol. Infect. 14 (2008) 66-73
22. Seifert K.N., Adderson E.E., Whiting A.A., Bohnsack J.F., Crowley P.J., and Brady L.J. A unique serine-rich repeat protein (Srr-2) and novel surface antigen (epsilon) associated with a virulent lineage of serotype III Streptococcus agalactiae. Microbiology 152 (2006) 1029-1040
23. Slotved H.C., Kong F., Lambertsen L., Sauer S., and Gilbert G.L. Serotype IX, a proposed new Streptococcus agalactiae serotype. J. Clin. Microbiol. 45 (2007) 2929-2936
24. Wang Y., Kong F., Gilbert G.L., Brown M., Gao W., Yu S., and Yang Y. Use of a multiplex PCR-based reverse line blot (mPCR/RLB) hybridisation assay for the rapid identification of bacterial pathogens. Clin. Microbiol. Infect. 14 (2008) 155-160
25. Wilkinson H.W. Comparison of streptococcal R antigens. Appl. Microbiol. 24 (1972) 669-670
26. Yang H.H., Madoff L.C., Guttormsen H.K., Liu Y.D., and Paoletti L.C. Recombinant group B streptococcus Beta C protein and a variant with the deletion of its immunoglobulin A-binding site are protective mouse maternal vaccines and effective carriers in conjugate vaccines. Infect. Immunol. 75 (2007) 3455-3461
27. Zhao Z., Kong F., and Gilbert G.L. Reverse line blot assay for direct identification of seven Streptococcus agalactiae major surface protein antigen genes. Clin. Vaccine Immunol. 13 (2006) 145-149
28. Zhao Z., Kong F., Zeng X., Gidding H.F., Morgan J., and Gilbert G.L. Distribution of genotypes and antibiotic resistance genes among invasive Streptococcus agalactiae (group B streptococcus) isolates from Australasian patients belonging to different age groups. Clin. Microbiol. Infect. 14 (2008) 260-267